ArticleBlood advances2017

Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy.

Zimu Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.